DNA SCHEDULE 13G/A: SEC filing

Viking Global Investors LP and affiliated entities

Filed with the SEC on · accession 0000905148-26-004952

DNA filed a SCHEDULE 13G/A (schedule 13g/a) with the SEC on Nov 16, 2026. A report the company filed with the SEC (the US market regulator). The stock moved -11.6% by the first close after the filing.

Summary of the filing

Viking Global Investors LP and affiliated entities filed an amended Schedule 13G reporting beneficial ownership of 2,900,025 shares, or 5.4%, of Ginkgo Bioworks Holdings Class A Common Stock as of September 30, 2026.

Key details

Shares of Class A Common Stock beneficially owned$2.9M
Percent of class beneficially ownedPCT 5
Reporting person / beneficial ownerViking Global Investors LP
Reporting person / beneficial ownerViking Global Opportunities Parent GP LLC
Reporting person / beneficial ownerViking Global Opportunities GP LLC
Reporting person / beneficial ownerViking Global Opportunities Portfolio GP LLC
Direct holder of sharesViking Global Opportunities Illiquid Investments Sub-Master LP
IssuerGinkgo Bioworks Holdings, Inc.
Executive committee member, viking global partners llcO. Andreas Halvorsen
Executive committee member, viking global partners llcRose S. Shabet

How DNA stock reacted

Close before

$9.61

Nov 13, 2026

First close after

-11.55%

$8.50

5 trading days

—

Since filing

—

✦ Ask GOAX AI about this filing — what it means for DNA, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for DNA?

Click here

Frequently asked questions

What did DNA file with the SEC on Nov 16, 2026?

DNA filed a SCHEDULE 13G/A (SEC filing). Viking Global Investors LP and affiliated entities filed an amended Schedule 13G reporting beneficial ownership of 2,900,025 shares, or 5.4%, of Ginkgo Bioworks Holdings Class A Common Stock as of September 30, 2026.

How do I read a SCHEDULE 13G/A?

A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13G/A (schedule 13g/a): A report the company filed with the SEC (the US market regulator).

How did DNA stock react to this filing?

DNA closed at $9.61 before the filing and $8.50 on Nov 16, 2026 (-11.55%).

Other DNA SEC filings

Get alerts when DNA files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days